Hemangio Journal

Tumors from younger dogs showed enhanced immune activation and chemotherapy sensitivity.

Published on: May 8, 2025

A new study examines the potential link between Bartonella infection and HSA, comparing detection methods and diagnostic challenges.

Published on: May 2, 2025

Serum TK1/CRP machine learning model identifies malignancies with 97% AUC accuracy.

Published on: April 29, 2025

Blood cell ratios could aid in detecting splenic tumors and forecasting prognosis in dogs.

Published on: April 17, 2025

Transcriptome analysis identifies key genes and miRNAs as potential biomarkers and therapeutic targets.

Published on: March 14, 2025

MiRNAs are particularly promising as diagnostic biomarkers, offering a non-invasive method that could be integrated into routine bloodwork.

Published on: February 26, 2025

They hope these findings will help refine treatment strategies and improve outcomes.

Published on: January 22, 2025

Hemangiosarcoma can have a very heterogeneous cytologic appearance that can be used to support a suspected diagnosis

Published on: January 21, 2025

Techniques show promise for early, non-invasive detection of canine hemangiosarcoma through cfDNA fragmentation and CNAs using machine learning.

Published on: January 24, 2025

Weak PTEN and strong EGFR expressions were linked to high-grade tumors, with EGFR activation of the PI3K/AKT pathway suggesting potential targets for canine soft tissue sarcoma therapy.

Published on: January 20, 2025

The results confirmed a low frequency of malignant splenic lesions and HSA in dogs, with a majority of diagnoses being benign masses.

Published on: January 20, 2025

Study shows low prevalence of occult cancer in older dogs, with physical exams and cytology being key diagnostic methods.

Published on: December 18, 2024